Core Insights - International Flavors (IFF) reported a revenue of $2.59 billion for the quarter ended December 2025, reflecting a year-over-year decline of 6.6% and an EPS of $0.80 compared to $0.97 a year ago, with a revenue surprise of +3.09% over the Zacks Consensus Estimate of $2.51 billion and an EPS surprise of -5.37% [1] Financial Performance - Net Sales in Health & Biosciences reached $589 million, exceeding the average estimate of $554.97 million by four analysts, representing a year-over-year increase of +6.5% [4] - Net Sales in Scent amounted to $610 million, surpassing the average estimate of $589.73 million, with a year-over-year change of +5.4% [4] - Net Sales in Taste were reported at $588 million, slightly above the average estimate of $578 million [4] - Net Sales in Food Ingredients totaled $802 million, compared to the average estimate of $797.21 million [4] Adjusted Operating EBITDA - Adjusted Operating EBITDA for Health & Biosciences was $155 million, exceeding the average estimate of $132.53 million [4] - Adjusted Operating EBITDA for Food Ingredients was $82 million, below the average estimate of $96.53 million [4] - Adjusted Operating EBITDA for Taste was $94 million, compared to the average estimate of $99.67 million [4] - Adjusted Operating EBITDA for Scent was $106 million, below the average estimate of $111.73 million [4] Stock Performance - Shares of International Flavors have returned +10.3% over the past month, contrasting with the Zacks S&P 500 composite's -0.3% change, and the stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]
International Flavors (IFF) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates